SPRO
Spero Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website erotherapeutics.com
- Employees(FY) 35
- ISIN US84833T1034
Performance
-5.92%
1W
+8.16%
1M
+3.92%
3M
+37.07%
6M
+8.16%
YTD
-12.64%
1Y
Profile
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, a direct acting IV-administered agent to treat MDR Gram-negative bacterial infections in the hospital; and SPR720, a novel oral antibiotic for the treatment of non-tuberculous mycobacterial pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; license agreement with Everest Medicines to develop, manufacture, and commercialize SPR206 in China, South Korea, and Southeast Asian countries; collaboration agreement with Bill & Melinda Gates Medical Research Institute to develop SPR720 for the treatment of lung infections caused by Mycobacterium tuberculosis; and license agreement with Vertex Pharmaceuticals Incorporated for patents relating to SPR720, as well as SPR719, an active metabolite. Spero Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Technical Analysis of SPRO 2024-05-10
Overview:
In analyzing the technical indicators for SPRO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions to guide investment ...
Recent News & Updates
- 2024-05-16 04:05
- 2024-05-15 08:55
- 2024-05-15 04:05
- 2024-05-07 20:00
- 2024-05-01 04:07
- 2024-04-15 23:52
14 Cheap Penny Stocks to Buy According to Analysts(Insidermonkey)
- 2024-03-15 00:51
- 2024-03-13 18:33
Q4 2023 Spero Therapeutics Inc Earnings Call(Yahoo Finance)
- 2024-03-13 05:10
- 2024-03-13 04:01
- 2024-03-05 19:05
- 2024-02-27 19:05
- 2024-02-25 19:05
- 2024-02-05 10:27
Spero Therapeutics Inc CEO Sath Shukla Sells 75,994 Shares(Yahoo Finance)
- 2024-01-31 03:05
- 2024-01-28 15:07
15 Cash-Rich Penny Stocks Hedge Funds Are Buying(Yahoo Finance)
- 2024-01-24 15:40
11 Hyper-Growth Stocks Billionaires Are Loading Up On(Yahoo Finance)
- 2024-01-04 19:05
- 2024-01-01 19:05
- 2023-11-13 20:02
- 2023-11-13 03:05
- 2023-11-05 19:05
- 2023-11-01 04:05
- 2023-10-31 20:05
- 2023-10-31 04:05
- 2023-10-18 00:00
- 2023-09-29 04:05
- 2023-09-20 04:05
- 2023-09-16 01:01
- 2023-09-11 20:00
Page 1 of 4
previousnext